Skip to main content

Advertisement

Log in

Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The clinical and pathological findings of plasmablastic lymphoma (PBL) have been described in the literature but the etiology is not well established, and treatment options are poorly defined. We reviewed patients with PBL in our institution to characterize the clinicopathologic features in our patient population. In this retrospective analysis from a single academic institution, five patients with PBL were identified and analyzed. Human immunodeficiency virus and human herpesvirus 8 (HHV-8) were identified in 40% (two out of five) and 80% (four out of five) of these patients, respectively. Central nervous system (CNS) involvement was identified in four out of five (80%) patients. Interestingly, three out of five patients had a concurrent or preceding second primary malignancy including small lymphocytic lymphoma, endometrial cancer, and nonsmall cell lung cancer. Most of the patients had advanced disease and a poor performance status at diagnosis. Only two of the patients received systemic chemotherapy with an initial partial response. All five patients died; the median overall survival was 1 month. Our experience in patients with PBL indicates that CNS involvement is more common than reported in the literature. Coexistence of a second primary malignancy may be frequent, and prognosis remains dismal with standard lymphoma therapy. Lastly, the role of HHV-8 in the etiopathogenesis needs further trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Armstrong R, Bradrick J, Liu YC (2007) Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report. J Oral Maxillofac Surg 65(7):1361–1364. doi:10.1016/j.joms.2005.12.039

    Article  PubMed  Google Scholar 

  2. Borenstein J, Pezzella F, Gatter KC (2007) Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 51(6):774–777. doi:10.1111/j.1365-2559.2007.02870.x

    Article  PubMed  CAS  Google Scholar 

  3. Borrero JJ, Pujol E, Perez S, Merino D, Montano A, Rodriguez FJ (2002) Plasmablastic lymphoma of the oral cavity and jaws. AIDS 16(14):1979–1980. doi:10.1097/00002030-200209270-00022

    Article  PubMed  Google Scholar 

  4. Brown RS, Campbell C, Lishman SC, Spittle MF, Miller RF (1998) Plasmablastic lymphoma: a new subcategory of human immunodeficiency virus-related non-Hodgkin’s lymphoma. Clin Oncol (R Coll Radiol) 10(5):327–329. doi:10.1016/S0936-6555(98)80089-7

    CAS  Google Scholar 

  5. Carbone A (2003) Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4(1):22–29. doi:10.1016/S1470-2045(03)00957-4

    Article  PubMed  CAS  Google Scholar 

  6. Carbone A, Gloghini A, Gaidano G (2004) Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 28(11):1538–1540. author reply 1540. doi:10.1097/01.pas.0000131533.21345.1c

    PubMed  Google Scholar 

  7. Carbone A, Gloghini A, Gaidano G (2008) KSHV/HHV8 doesn’t play a significant role in the development of plasmablastic lymphoma of the oral cavity. Am J Surg Pathol 32(1):172–174

    Google Scholar 

  8. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS (2002) Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298(5597):1432–1435. doi:10.1126/science.1074883

    Article  PubMed  CAS  Google Scholar 

  9. Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K (2003) Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 42(6):605–609. doi:10.1046/j.1365-2559.2003.01636.x

    Article  PubMed  CAS  Google Scholar 

  10. Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ (2004) Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 28(1):41–46. doi:10.1097/00000478-200401000-00003

    Article  PubMed  Google Scholar 

  11. The Non-Hodgkin’s Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 89(11):3909–3918

    Google Scholar 

  12. Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A et al (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736–747. doi:10.1097/01.pas.0000126781.87158.e3

    Article  PubMed  Google Scholar 

  13. Dawson MA, Schwarer AP, McLean C, Oei P, Campbell LJ, Wright E et al (2007) AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation–treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica 92(1):e11–e12. doi:10.3324/haematol.10933

    Article  PubMed  Google Scholar 

  14. Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89(4):1413–1420

    PubMed  CAS  Google Scholar 

  15. Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST (2005) High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 19(5):851–855. doi:10.1038/sj.leu.2403709

    Article  PubMed  CAS  Google Scholar 

  16. Dong HY, Scadden DT, de Leval L, Tang Z, Isaacson PG, Harris NL (2005) Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein–Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 29(12):1633–1641. doi:10.1097/01.pas.0000173023.02724.1f

    Article  PubMed  Google Scholar 

  17. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D et al (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95(4):1406–1412

    PubMed  CAS  Google Scholar 

  18. Flaitz CM, Nichols CM, Walling DM, Hicks MJ (2002) Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol 38(1):96–102. doi:10.1016/S1368-8375(01)00018-5

    Article  PubMed  CAS  Google Scholar 

  19. Foltyn W, Kos-Kudla B, Sieminska L, Zemczak A, Strzelczyk J, Marek B et al (2006) Unique case of caecum plasmablastic lymphoma CD138(+) in patient with late diagnosed colon neuroendocrine carcinoma. Endokrynol Pol 57(2):160–165

    PubMed  Google Scholar 

  20. Gessain A, Sudaka A, Briere J, Fouchard N, Nicola MA, Rio B et al (1996) Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman’s disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 87(1):414–416

    PubMed  CAS  Google Scholar 

  21. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Tumors of hematopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  22. Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R et al (2003) Kaposi’s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A 100(18):10399–10404. doi:10.1073/pnas.1630810100

    Article  PubMed  CAS  Google Scholar 

  23. Kuhnen C, Schneele H, Muller KM (1994) Malignant lymphoma and colon carcinoma 3 years after heart transplantation and immunosuppression. Pathologe 15(2):129–133. doi:10.1007/s002920050036

    Article  PubMed  CAS  Google Scholar 

  24. Lester R, Li C, Phillips P, Shenkier TN, Gascoyne RD, Galbraith PF et al (2004) Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 45(9):1881–1885. doi:10.1080/10428190410001697395

    Article  PubMed  Google Scholar 

  25. Li H, Wang H, Nicholas J (2001) Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling. J Virol 75(7):3325–3334. doi:10.1128/JVI.75.7.3325-3334.2001

    Article  PubMed  CAS  Google Scholar 

  26. Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM (2005) AIDS-related Burkitt’s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430–4438. doi:10.1200/JCO.2005.11.973

    Article  PubMed  CAS  Google Scholar 

  27. Lin F, Zhang K, Quiery AT Jr, Prichard J, Schuerch C (2004) Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 128(5):581–584

    PubMed  Google Scholar 

  28. Lin O, Gerhard R, Zerbini MC, Teruya-Feldstein J (2005) Cytologic features of plasmablastic lymphoma. Cancer 105(3):139–144. doi:10.1002/cncr.21036

    Article  PubMed  Google Scholar 

  29. Liu W, Lacouture ME, Jiang J, Kraus M, Dickstein J, Soltani K et al (2006) KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman’s disease and Kaposi’s sarcoma. J Cutan Pathol 33(Suppl 2):46–51. doi:10.1111/j.1600-0560.2006.00539.x

    Article  PubMed  CAS  Google Scholar 

  30. Masgala A, Christopoulos C, Giannakou N, Boukis H, Papadaki T, Anevlavis E (2007) Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol 86(8):615–618. doi:10.1007/s00277-007-0280-z

    Article  PubMed  Google Scholar 

  31. Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG (2000) Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 96(8):2730–2734

    PubMed  CAS  Google Scholar 

  32. Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM (2002) Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 43(2):423–426. doi:10.1080/10428190290006260

    Article  PubMed  Google Scholar 

  33. Nguyen DD, Loo BW Jr, Tillman G, Natkunam Y, Cao TM, Vaughan W et al (2003) Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 82(8):521–525. doi:10.1007/s00277-003-0684-3

    Article  PubMed  CAS  Google Scholar 

  34. Panos G, Karveli EA, Nikolatou O, Falagas ME (2007) Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol 82(8):761–765. doi:10.1002/ajh.20807

    Article  PubMed  Google Scholar 

  35. Porter SR, Diz Dios P, Kumar N, Stock C, Barrett AW, Scully C (1999) Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87(6):730–734. doi:10.1016/S1079-2104(99)70170-8

    Article  PubMed  CAS  Google Scholar 

  36. Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R (1998) Plasmablastic lymphoma of the stomach. A case report. Haematologica 83(1):87–89

    PubMed  CAS  Google Scholar 

  37. Ramalingam P, Nayak-Kapoor A, Reid-Nicholson M, Crawford J, Ustun C (2008) Plasmablastic lymphoma with small lymphocytic lymphoma: clinico-pathologic features, and review of the literature. Leuk Lymphoma 18:1–4

    Google Scholar 

  38. Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171–2178

    PubMed  CAS  Google Scholar 

  39. Reece DE (2007) Management of multiple myeloma: the changing landscape. Blood Rev 21(6):301–314. doi:10.1016/j.blre.2007.07.001

    Article  PubMed  CAS  Google Scholar 

  40. Reid-Nicholson M, Kavuri S, Ustun C, Crawford J, Nayak-Kapoor A, Ramalingam P (2008) Plasmablastic lymphoma: cytologic findings in 5 cases with unusual presentation. Cancer (in press)

  41. Riedel DJ, Gonzalez-Cuyar LF, Zhao XF, Redfield RR, Gilliam BL (2008) Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis 8(4):261–267. doi:10.1016/S1473-3099(08)70067-7

    Article  PubMed  Google Scholar 

  42. Robak T, Urbanska-Rys H, Strzelecka B, Krykowski E, Bartkowiak J, Blonski JZ et al (2001) Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter’s syndrome. Eur J Haematol 67(5–6):322–327. doi:10.1034/j.1600-0609.2001.00592.x

    Article  PubMed  CAS  Google Scholar 

  43. Shuangshoti S, Assanasen T, Lerdlum S, Srikijvilaikul T, Intragumtornchai T, Thorner PS (2007) Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol 34:245–247

    Article  PubMed  Google Scholar 

  44. Song J, Ohkura T, Sugimoto M, Mori Y, Inagi R, Yamanishi K et al (2002) Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol 68(3):404–411. doi:10.1002/jmv.10218

    Article  PubMed  CAS  Google Scholar 

  45. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P et al (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86(4):1276–1280

    PubMed  CAS  Google Scholar 

  46. Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M et al (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–1679. doi:10.1093/annonc/mdh399

    Article  PubMed  CAS  Google Scholar 

  47. Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC et al (2005) Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 18(6):806–815. doi:10.1038/modpathol.3800355

    Article  PubMed  Google Scholar 

  48. Verma S, Nuovo GJ, Porcu P, Baiocchi RA, Crowson AN, Magro CM (2005) Epstein–Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 32(1):35–39. doi:10.1111/j.0303-6987.2005.00258.x

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

We would like to acknowledge Teresa Coleman, MD and David Deremer, Pharm D for their contribution in editing the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Celalettin Ustun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ustun, C., Reid-Nicholson, M., Nayak-Kapoor, A. et al. Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol 88, 351–358 (2009). https://doi.org/10.1007/s00277-008-0601-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0601-x

Keywords

Navigation